These previously defined actions of RANKL on inducing insulin resistance may be linked to our finding that DMAb reduced circulating DPP4 and increased GLP-1 levels, in that both DPP4 inhibitors54 and GLP-155 may also reduce insulin resistance. Here, TNFSF11 is linked to Insulin resistance.